Search Results

There are 23679 results for: content related to: Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs

  1. Enteric-coated mycophenolate sodium containing GvHD prophylaxis reduces GvHD rate after allogeneic HSCT

    European Journal of Haematology

    Volume 97, Issue 3, September 2016, Pages: 232–238, Thomas Weber, Jonas Niestadtkötter, Andreas Wienke, Carsten Müller-Tidow and Lutz P. Müller

    Version of Record online : 14 JAN 2016, DOI: 10.1111/ejh.12710

  2. Treatment of five haemodynamically stable dogs with immune-mediated thrombocytopenia using mycophenolate mofetil as single agent

    Journal of Small Animal Practice

    Volume 55, Issue 6, June 2014, Pages: 330–333, V. K. Yau and D. Bianco

    Version of Record online : 7 MAR 2014, DOI: 10.1111/jsap.12203

  3. Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011)

    Journal of Small Animal Practice

    Volume 54, Issue 8, August 2013, Pages: 399–404, A. Wang, J. R. Smith and K. E. Creevy

    Version of Record online : 23 JUL 2013, DOI: 10.1111/jsap.12107

  4. Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies

    Clinical Transplantation

    Volume 22, Issue 6, November/December 2008, Pages: 815–821, Suphamai Bunnapradist and Patrice M. Ambühl

    Version of Record online : 16 SEP 2008, DOI: 10.1111/j.1399-0012.2008.00892.x

  5. Mycophenolates in transplantation

    Clinical Transplantation

    Volume 18, Issue 5, October 2004, Pages: 485–492, Hans W Sollinger

    Version of Record online : 1 SEP 2004, DOI: 10.1111/j.1399-0012.2004.00203.x

  6. EC-MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF-related gastrointestinal side-effects

    Fundamental & Clinical Pharmacology

    Volume 23, Issue 5, October 2009, Pages: 617–624, Massimo Sabbatini, Domenico Capone, Riccardo Gallo, Antonio Pisani, Giuliano Polichetti, Giovanni Tarantino, Antonio Gentile, Eliana Rotaia and Stefano Federico

    Version of Record online : 28 JUL 2009, DOI: 10.1111/j.1472-8206.2009.00711.x

  7. Impact of mycophenolate mofetil on recurrent rejection in kidney transplant patients

    Clinical Transplantation

    Volume 15, Issue 4, August 2001, Pages: 253–257, EM Vasquez, NM Sifontis, R Pollak and E Benedetti

    Version of Record online : 12 JAN 2002, DOI: 10.1034/j.1399-0012.2001.150406.x

  8. Is EC-MPS effective in reducing GI toxicity of MPA? At what price?

    Pediatric Transplantation

    Volume 13, Issue 6, September 2009, Pages: 659–660, Lars Pape and Thurid Ahlenstiel

    Version of Record online : 6 JUL 2009, DOI: 10.1111/j.1399-3046.2009.01207.x

  9. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation

    Clinical Transplantation

    Volume 20, Issue 3, May/June 2006, Pages: 272–283, Jan M. Langrehr, Jochen Klupp, Matthias Glanemann, Guido Junge, Robert Pfitzmann, Marcus Bahra, Cornelia Radtke, Ulf Neumann, Ruth Neuhaus and Peter Neuhaus

    Version of Record online : 28 MAR 2006, DOI: 10.1111/j.1399-0012.2005.00485.x

  10. Improvement of gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients

    Clinical Transplantation

    Volume 26, Issue 1, January/February 2012, Pages: 156–163, Alexander H. Toledo, Laura Hendrix, Valorie Buchholz, Erin Fisher, Kimberly Newton, Courtney Smith and David A. Gerber

    Version of Record online : 7 APR 2011, DOI: 10.1111/j.1399-0012.2011.01444.x

  11. You have free access to this content
    Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients

    Intervention Review

    The Cochrane Library

    Martin Wagner, Amy K Earley, Angela C Webster, Christopher H Schmid, Ethan M Balk and Katrin Uhlig

    Published Online : 3 DEC 2015, DOI: 10.1002/14651858.CD007746.pub2

  12. You have free access to this content
    American Transplant Congress 2007 Executive and Program Planning Committees and Abstract Review Committees

    American Journal of Transplantation

    Volume 7, Issue s2, May 2007, Pages: 17–584,

    Version of Record online : 26 APR 2007, DOI: 10.1111/j.1600-6143.2007.01811.x

  13. You have free access to this content
    TRANSPLANT 2001: The Joint American Transplant Meeting

    American Journal of Transplantation

    Volume 1, Issue S1, May 2001, Pages: 47–476,

    Version of Record online : 25 AUG 2010, DOI: 10.1111/j.1600-6143.2001.tb00014.x

  14. Long-Term Changes in Mycophenolic Acid Exposure in Combination with Tacrolimus and Corticosteroids Are Dose Dependent and Not Reflected by Trough Plasma Concentration: A Prospective Study in 100 De Novo Renal Allograft Recipients

    The Journal of Clinical Pharmacology

    Volume 43, Issue 8, August 2003, Pages: 866–880, Dr. D. R. J. Kuypers, Dr. K. Claes, Dr. P. Evenepoel, Dr. B. Maes, Dr. W. Coosemans, Dr. J. Pirenne and Dr. Y. Vanrenterghem

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270003256151

  15. UGT Genotype May Contribute to Adverse Events Following Medication With Mycophenolate Mofetil in Pediatric Kidney Transplant Recipients

    Clinical Pharmacology & Therapeutics

    Volume 85, Issue 5, May 2009, Pages: 495–500, SE Prausa, T Fukuda, D Maseck, KL Curtsinger, C Liu, K Zhang, TG Nick, JR Sherbotie, EN Ellis, J Goebel and AA Vinks

    Version of Record online : 18 FEB 2009, DOI: 10.1038/clpt.2009.3

  16. You have free access to this content
    Calcineurin Inhibitor–Free Mycophenolate Mofetil/Sirolimus Maintenance in Liver Transplantation: The Randomized Spare-the-Nephron Trial

    Liver Transplantation

    Volume 19, Issue 7, July 2013, Pages: 675–689, Lewis Teperman, Dilip Moonka, Anthony Sebastian, Linda Sher, Paul Marotta, Christopher Marsh, Baburao Koneru, John Goss, Dennis Preston, John P. Roberts and for the Spare-the-Nephron Trial Liver Transplantation Study Group

    Version of Record online : 25 JUN 2013, DOI: 10.1002/lt.23658

  17. Can mycophenolate mofetil be tapered safely in myasthenia gravis? A retrospective, multicenter analysis

    Muscle & Nerve

    Volume 52, Issue 2, August 2015, Pages: 211–215, Lisa D. Hobson-Webb, Michael Hehir, Brian Crum, Amy Visser, Donald Sanders and Ted M. Burns

    Version of Record online : 18 JUN 2015, DOI: 10.1002/mus.24694

  18. Treatment of primary immune-mediated hemolytic anemia with mycophenolate mofetil in two cats

    Journal of Veterinary Emergency and Critical Care

    Volume 21, Issue 1, February 2011, Pages: 45–49, Lenore M. Bacek and Douglass K. Macintire

    Version of Record online : 11 JAN 2011, DOI: 10.1111/j.1476-4431.2010.00606.x

    Corrected by:

    Treatment of primary immune-mediated hemolytic anemia with mycophenolate mofetil in two cats

    Vol. 21, Issue 3, 285, Version of Record online: 1 JUN 2011

  19. Use of enteric-coated mycophenolate sodium in liver transplant patients with intestinal intolerance caused by mycophenolate mofetil

    Clinical Transplantation

    Volume 23, Issue 6, November/December 2009, Pages: 882–886, Cataldo Doria, Carlo B. Ramirez, Adam M. Frank, Silvia Vaccino, Natalie Fraser and Ignazio R. Marino

    Version of Record online : 30 JUN 2009, DOI: 10.1111/j.1399-0012.2009.01019.x

  20. Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients

    Clinical Transplantation

    Volume 19, Issue 6, December 2005, Pages: 779–784, JC Tierce, J Porterfield-Baxa, AA Petrilla, A Kilburg and RM Ferguson

    Version of Record online : 19 JUL 2005, DOI: 10.1111/j.1399-0012.2005.00421.x